Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

Public consultation – FDA Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry (Cell and Gene Therapy Catapult – Regulatory Round-up – January 2023)

Title :  Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry

End date :14 March 2023

Category: Draft guidance

See all of Catapult’s Regulatory Round-up for January 2023 here. Published on the 1st of February 2023.


OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (17 mai 2023). Public consultation – FDA Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products — Content and Format Guidance for Industry (Cell and Gene Therapy Catapult – Regulatory Round-up – January 2023). ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/o6b0


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.